Island Pharmaceuticals Requests Trading Halt Pending Antiviral Drug Candidate Trial Update
() -- Island Pharmaceuticals (ASX:ILA) requested a trading halt on the Australian Securities Exchange, pending an update regarding the potential inclusion of its antiviral candidate, galidesivir, in an Ebola clinical trial in Africa, according to a Friday filing with the Australian bourse. The halt will remain in effec